Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Bromodomain containing protein | 0.0087 | 0.222 | 0.2082 |
Plasmodium vivax | amine transporter, putative | 0.0052 | 0.0998 | 0.5 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0307 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.2046 | 0.2046 |
Schistosoma mansoni | sodium-dependent amino acid transporter | 0.0052 | 0.0998 | 0.0998 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0052 | 0.0998 | 0.0998 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0998 | 0.0998 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0998 | 0.1764 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.0052 | 0.0998 | 0.0998 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0998 | 0.0998 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0307 | 1 | 0.5 |
Trypanosoma cruzi | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0083 | 0.2083 | 0.2066 |
Echinococcus multilocularis | serotonin transporter | 0.0307 | 1 | 1 |
Echinococcus granulosus | serotonin transporter | 0.0307 | 1 | 1 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0052 | 0.0998 | 0.0998 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0998 | 0.0838 |
Loa Loa (eye worm) | serotonin transporter b | 0.0307 | 1 | 1 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0237 | 0.7527 | 1 |
Schistosoma mansoni | sodium-dependent neurotransmitter transporter | 0.0052 | 0.0998 | 0.0998 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0998 | 0.1764 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0052 | 0.0998 | 0.0998 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0998 | 0.0998 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0998 | 0.0838 |
Toxoplasma gondii | hypothetical protein | 0.0052 | 0.0998 | 0.1764 |
Echinococcus granulosus | sodium and chloride dependent glycine | 0.0052 | 0.0998 | 0.0927 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0899 | 0.0899 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0307 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0998 | 0.0998 |
Brugia malayi | Inositol-1 | 0.0043 | 0.0666 | 0.05 |
Onchocerca volvulus | 0.0307 | 1 | 1 | |
Echinococcus multilocularis | sodium and chloride dependent glycine | 0.0052 | 0.0998 | 0.0927 |
Schistosoma mansoni | inositol monophosphatase | 0.0043 | 0.0666 | 0.0666 |
Leishmania major | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0083 | 0.2083 | 0.2066 |
Echinococcus multilocularis | uncharacterized sodium dependent transporter | 0.0052 | 0.0998 | 0.0927 |
Plasmodium vivax | hypothetical protein, conserved | 0.0052 | 0.0998 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0998 | 0.0998 |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.0043 | 0.0666 | 0.5 |
Brugia malayi | kinase, mitochondrial precursor | 0.0237 | 0.7527 | 0.7483 |
Toxoplasma gondii | pyruvate dehydrogenase kinase, putative | 0.0083 | 0.2083 | 0.7528 |
Brugia malayi | hypothetical protein | 0.0052 | 0.0998 | 0.0838 |
Echinococcus multilocularis | sodium:chloride dependent neurotransmitter | 0.0052 | 0.0998 | 0.0927 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0038 | 0.0508 | 0.5 |
Plasmodium falciparum | transporter, putative | 0.0052 | 0.0998 | 0.5 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0237 | 0.7527 | 0.7527 |
Loa Loa (eye worm) | hypothetical protein | 0.0307 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0307 | 1 | 1 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0307 | 1 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0224 | 0.7062 | 0.7062 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0998 | 0.0838 |
Schistosoma mansoni | inositol monophosphatase | 0.0043 | 0.0666 | 0.0666 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0237 | 0.7527 | 1 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0043 | 0.0666 | 0.5 |
Schistosoma mansoni | sodium-dependent neurotransmitter transporter | 0.0052 | 0.0998 | 0.0998 |
Echinococcus granulosus | uncharacterized sodium dependent transporter | 0.0052 | 0.0998 | 0.0927 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0998 | 0.0998 |
Echinococcus granulosus | sodium dependent neurotransmitter transporter | 0.0052 | 0.0998 | 0.0927 |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.0043 | 0.0666 | 0.0592 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.0821 | 0.0821 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.0052 | 0.0998 | 0.0998 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0998 | 0.0998 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0069 | 0.1595 | 0.1529 |
Echinococcus granulosus | sodium and chloride dependent glycine | 0.0052 | 0.0998 | 0.0927 |
Echinococcus multilocularis | sodium and chloride dependent glycine | 0.0052 | 0.0998 | 0.0927 |
Loa Loa (eye worm) | inositol-1 | 0.0043 | 0.0666 | 0.0666 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0998 | 0.1764 |
Schistosoma mansoni | bromodomain containing protein | 0.0073 | 0.1742 | 0.1742 |
Echinococcus granulosus | sodium:chloride dependent neurotransmitter | 0.0052 | 0.0998 | 0.0927 |
Plasmodium falciparum | amino acid transporter, putative | 0.0052 | 0.0998 | 0.5 |
Echinococcus multilocularis | sodium dependent neurotransmitter transporter | 0.0052 | 0.0998 | 0.0927 |
Schistosoma mansoni | sodium-dependent neurotransmitter transporter | 0.0052 | 0.0998 | 0.0998 |
Echinococcus granulosus | uncharacterized sodium dependent transporter | 0.0052 | 0.0998 | 0.0927 |
Brugia malayi | Bromodomain containing protein | 0.0044 | 0.0721 | 0.0556 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0237 | 0.7527 | 0.7508 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0625 | 0.0551 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0043 | 0.0666 | 0.5 |
Trypanosoma brucei | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0083 | 0.2083 | 0.2066 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0026 | 0.0078 | 0.0078 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0052 | 0.0998 | 0.0998 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0096 | 0.2549 | 1 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0038 | 0.0508 | 0.5 |
Loa Loa (eye worm) | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0998 | 0.0998 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0307 | 1 | 1 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0237 | 0.7527 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0224 | 0.7062 | 0.7062 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.0237 | 0.7527 | 0.7508 |
Loa Loa (eye worm) | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0998 | 0.0998 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0724 | 0.0724 |
Toxoplasma gondii | hypothetical protein | 0.0052 | 0.0998 | 0.1764 |
Loa Loa (eye worm) | hypothetical protein | 0.0307 | 1 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0237 | 0.7527 | 0.7508 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0043 | 0.0666 | 0.5 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0043 | 0.0666 | 0.5 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.0043 | 0.0666 | 0.0592 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0069 | 0.1595 | 0.1529 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0043 | 0.0666 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0237 | 0.7527 | 0.7527 |
Brugia malayi | Sodium:neurotransmitter symporter family protein 1, putative | 0.0052 | 0.0998 | 0.0838 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.0052 | 0.0998 | 0.0998 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0625 | 0.0551 |
Chlamydia trachomatis | Ssodium-dependent amino acid transporter | 0.0052 | 0.0998 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (ADMET) | Neurotoxicity in albino Carworth Farms No.1 mouse assessed as motor impairment at 300 mg/kg, ip after 0.5 hrs by rotarod test | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against maximal electroshock-induced seizure at 100 mg/kg, ip after 4 hrs | ChEMBL. | 21862182 | |
Activity (ADMET) | Neurotoxicity in albino Carworth Farms No.1 mouse assessed as motor impairment at 30 mg/kg, ip after 0.5 hrs by rotarod test | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against maximal electroshock-induced seizure at 300 mg/kg, ip after 4 hrs | ChEMBL. | 21862182 | |
Activity (ADMET) | Neurotoxicity in albino Carworth Farms No.1 mouse assessed as motor impairment at 300 mg/kg, ip after 4 hrs by rotarod test | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against subcutaneous metrazol-induced seizure at 300 mg/kg, ip after 4 hrs | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against subcutaneous metrazol-induced seizure at 30 mg/kg, ip after 4 hrs | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against subcutaneous metrazol-induced seizure at 100 mg/kg, ip after 0.5 hrs | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against maximal electroshock-induced seizure at 100 mg/kg, ip after 0.5 hrs | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against maximal electroshock-induced seizure at 300 mg/kg, ip after 0.5 hrs | ChEMBL. | 21862182 | |
Activity (ADMET) | Neurotoxicity in albino Carworth Farms No.1 mouse assessed as motor impairment at 100 mg/kg, ip after 0.5 hrs by rotarod test | ChEMBL. | 21862182 | |
Activity (ADMET) | Neurotoxicity in albino Carworth Farms No.1 mouse assessed as motor impairment at 30 mg/kg, ip after 4 hrs by rotarod test | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against subcutaneous metrazol-induced seizure at 300 mg/kg, ip after 0.5 hrs | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against subcutaneous metrazol-induced seizure at 30 mg/kg, ip after 0.5 hrs | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against maximal electroshock-induced seizure at 30 mg/kg, ip after 4 hrs | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against maximal electroshock-induced seizure at 30 mg/kg, ip after 0.5 hrs | ChEMBL. | 21862182 | |
Activity (functional) | Anticonvulsant activity in albino Carworth Farms No.1 mouse assessed as protection against subcutaneous metrazol-induced seizure at 100 mg/kg, ip after 4 hrs | ChEMBL. | 21862182 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.